$NBO $LLY Eli Lilly (LLY) fell in premarket trading after Bloomberg reported that weekly prescriptions for the company’s weight loss therapies, Foundayo and Zepbound, trailed those for Novo Nordisk’s (NVO) rival drug, Wegovy, according to IQVIA (IQV) data sourced by analysts.
$NBH $NBO $NBW NEUBERGER BERMAN MUNICIPAL FUND ANNOUNCES MONTHLY DISTRIBUTION AND EXPECTED CLOSING OF REORGANIZATIONS
https://www.stocktitan.net/news/NBH/neuberger-berman-municipal-fund-announces-monthly-distribution-and-hrz3bdtwkdrc.html
From 7/11/2023, looking back across 22 Month-Ends for NBO, Percentage Change of Average Monthly Price had More Negatives (64%) while Percentage Change of Average Monthly Volume had All Positives (100%) $NBO #NBO #NBOStock #TickerDD #NBOPrice https://www.youtube.com/watch?v=-2146826273
Although the technical rating is bad, $NBO does present a nice setup opportunity. https://www.chartmill.com/stock/quote/NBO/technical-analysis?key=de2b8db6-cd0f-48d3-ab9b-b6bc696953fa&utm_source=stocktwits&utm_medium=TA&utm_content=NBO&utm_campaign=social_tracking
$NBO Form NPORT-P (monthly portfolio investments report on form n-port (public)) filed with the SEC
https://newsfilter.io/a/ea7532c223b1bedb3f448d9927496e00
